hemodialysis

1.To observe the influence of hemodiafiltration(HDF) on cardiovascular stability of older hemodialysis(HD) patients.

观察液透析滤过(HDF)透析患者心管定性的影响。

2.Conclusion The hyponatremia patients can use hemodialysis when dieresis had no effect, combine heart failure or hypervolemia.

结论症患者如果利尿效果不佳或合并有心力衰竭或高容量时,可以考虑液透析治疗。

3.Thetimes of hypotension, hypertension, arythmia and stenocardia during hemodialysis were different between the elderly and the youthful gaups;

组透过程中压、高压、心律失常及心绞痛发生例次与青组比较有差异。

4.Objective To observe effects of hemodiafiltration(HDF) and hemodialysis(HD)on uremic encephalopathy(UE).

目的观察液透析滤过(HDF)及液透析(HD)尿毒症脑病的疗效。

5.Objective To perspectively evaluate the prevalence and clinical characteristics of acquired cystic kidney disease and renal cell carcinoma in hemodialysis patients.

目的 提高长期液透析患者获得性肾囊肿及肾细胞癌的发病和临床特点的认识。

6.Applied during hemodialysis, the effect rate were 8.3%, 71.4%, 68.2% respectively in midodrine hydrochloride tablet group compound amino acid group, 50% glucose group.

在透析中出现症状后应用，有效率分别为：盐酸米多君8.3%，复方氨基酸71.4%，50%葡萄糖68.2%。